Table 1.
Characteristics of the study population (n = 14).
| Age (years, mean(SD)) | 68.4 (10.0) | |
| Sex (male (n(%))) | 11 (79%) | |
| HTN (n(%)) | 12 (86%) | |
| Diabetes (n(%)) | 2 (14%) | |
| Current smoker (n(%)) | 0 (0%) | |
| Indication for CA/PCI | ||
| IHD (n(%)) | 10 (71%) | |
| Others (n(%)) | 4 (29%) | |
| Invasive Blood Pressure (mmHg) | ||
| First measurement | SBP | 122.7 (20.4) |
| DBP | 67.8 (16.3) | |
| Second Measurement | SBP | 128.2 (23.1) |
| DBP | 69.4 (14.7) | |
| Brachial Cuff Blood Pressure (mmHg) | ||
| First Measurement | SBP | 119.8 (24.7) |
| DBP | 74.3 (12.8) | |
| Second Measurement | SBP | 130.8 (26.4) |
| DBP | 76.4 (13.2) | |
| Beat to Beat Blood Pressure (mmHg) | ||
| First Measurement | SBP | 158.1 (29.3) |
| DBP | 93.9 (23.1) | |
| Second Measurement | SBP | 161.4 (36.0) |
| DBP | 96.2 (24.3) | |
| Medications | ||
| ACEi/ARBs (n(%)) | 10 (71%) | |
| Beta blockers (n(%)) | 7 (50%) | |
| Calcium Channel Blockers (n(%)) | 3 (21%) | |
| Antiplatelets (n(%)) | 10 (71%) | |
| Anticoagulants (n(%)) | 1 (7%) | |
| Diuretics (n(%)) | 3 (21%) | |
| Statins (n(%)) | 8 (57%) | |
HTN, hypertension; CA, coronary angiography; PCI, percutaneous coronary intervention; IHD, ischemic heart disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEi, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers.